{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:06:25Z","timestamp":1792807585561,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["Grant number JP23K08433"],"award-info":[{"award-number":["Grant number JP23K08433"]}]},{"name":"Konan Chemical Manufacturing Co., Ltd","award":["Konan Chemical Manufacturing Co., Ltd"],"award-info":[{"award-number":["Konan Chemical Manufacturing Co., Ltd"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis damages endothelial cells through glycocalyx degradation, contributing to organ dysfunction. Glycocalyx repair is essential for recovery, but the underlying mechanisms remain unclear. Rhamnan sulfate (RS), a sulfated polysaccharide with anti-inflammatory properties, may support endothelial glycocalyx repair. In this study, we investigated the glycocalyx repair process and the therapeutic potential of RS using a mouse sepsis model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sepsis was induced in male C57BL\/6 mice by cecal ligation and puncture (CLP). Mice were divided into the RS, control (CTL), and sham groups. RS was orally administered to the RS group, while the CTL group received no treatment after CLP. Sham mice underwent laparotomy only without CLP. Endothelial glycocalyx repair was evaluated using transmission electron microscopy (TEM) and scanning electron microscopy (SEM), and quantitative TEM analysis. Gene expressions of glycocalyx-related enzymes and inflammatory cytokines were assessed in liver and small intestine tissues by quantitative real-time PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 7-day survival rate after CLP was significantly higher in the RS group (55%) than in the CTL group (25%). TEM and SEM demonstrated that in the CTL group, the endothelial glycocalyx remained disrupted for up to 72\u00a0h after CLP but by two weeks had undergone compensatory regeneration with thickening, exceeding that observed in sham-treated mice. In contrast, in the RS group, glycocalyx continuity was restored by 72\u00a0h and normalized to levels comparable to those of the sham-treated group by two weeks. Quantitative TEM analysis supported marked structural alteration of glycocalyx after CLP and normalization of glycocalyx thickness toward sham levels after RS treatment. Quantitative real-time PCR revealed a significant increase in inflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1) after CLP, which tended to be lower in the RS-treated group. A similar trend was observed for the glycocalyx-degrading enzymes heparanase and hyaluronidase, whose expression was also suppressed by RS treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Electron microscopy allowed detailed observation of endothelial glycocalyx repair in septic mice. RS promoted glycocalyx repair and reduced inflammation, suggesting that administration of RS may be a novel therapeutic strategy for maintaining vascular integrity in sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-026-00954-w","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:52:07Z","timestamp":1784530327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sepsis-induced endothelial glycocalyx disruption and remodeling: an ultrastructural study in mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Ryo","family":"Hisamune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-4021","authenticated-orcid":false,"given":"Kazuma","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhide","family":"Kayano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Oide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Terasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"954_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (SEPSIS-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS et al (2016) Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:775\u2013787","journal-title":"JAMA"},{"key":"954_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Jones G, David S, Olariu E, Cadwell KK (2019) Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care 23:196","journal-title":"Crit Care"},{"key":"954_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395:200\u2013211","journal-title":"Lancet"},{"key":"954_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","volume":"454","author":"S Reitsma","year":"2007","unstructured":"Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG (2007) The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 454:345\u2013359","journal-title":"Pflugers Arch"},{"key":"954_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13054-015-0741-z","volume":"19","author":"C Chelazzi","year":"2015","unstructured":"Chelazzi C, Villa G, Mancinelli P, De Gaudio AR, Adembri C (2015) Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care 19:26","journal-title":"Crit Care"},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","volume":"45","author":"C Ince","year":"2016","unstructured":"Ince C, Mayeux PR, Nguyen T, Gomez H, Kellum JA, Ospina-Tasc\u00f3n GA et al (2016) The endothelium in sepsis. Shock 45:259\u2013270","journal-title":"Shock"},{"key":"954_CR8","doi-asserted-by":"publisher","first-page":"e896","DOI":"10.1002\/ams2.896","volume":"10","author":"K Suzuki","year":"2023","unstructured":"Suzuki K, Miura T, Okada H (2023) The endothelial glycocalyx\u2013All the same? No, it is not. Acute Med Surg 10:e896","journal-title":"Acute Med Surg"},{"key":"954_CR9","doi-asserted-by":"publisher","first-page":"91350","DOI":"10.18632\/oncotarget.20518","volume":"8","author":"T Li","year":"2017","unstructured":"Li T, Liu X, Zhao Z, Ni L, Liu C (2017) Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon-injury rat carotid artery model. Oncotarget 8:91350\u201391361","journal-title":"Oncotarget"},{"key":"954_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/187152909788488708","volume":"9","author":"AJ Drake-Holland","year":"2009","unstructured":"Drake-Holland AJ, Noble MI (2009) The important new drug target in cardiovascular medicine\u2013the vascular glycocalyx. Cardiovasc Hematol Disord Drug Targets 9:118\u2013123","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"954_CR11","doi-asserted-by":"publisher","first-page":"897087","DOI":"10.3389\/fcvm.2022.897087","volume":"9","author":"A Milusev","year":"2022","unstructured":"Milusev A, Rieben R, Sorvillo N (2022) The endothelial glycocalyx: a possible therapeutic target in cardiovascular disorders. Front Cardiovasc Med 9:897087","journal-title":"Front Cardiovasc Med"},{"key":"954_CR12","doi-asserted-by":"publisher","first-page":"17328","DOI":"10.1021\/acs.iecr.1c03074","volume":"60","author":"A Banerjee","year":"2021","unstructured":"Banerjee A, Mwangi JG, Stanley TK, Mitra R, Ebong EE (2021) Regeneration and assessment of the endothelial glycocalyx to address cardiovascular disease. Ind Eng Chem Res 60:17328\u201317347","journal-title":"Ind Eng Chem Res"},{"key":"954_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s11418-019-01289-5","volume":"73","author":"T Okamoto","year":"2019","unstructured":"Okamoto T, Akita N, Terasawa M, Hayashi T, Suzuki K (2019) Rhamnan sulfate extracted from Monostroma nitidum attenuates blood coagulation and inflammation of vascular endothelial cells. J Nat Med 73:614\u2013619","journal-title":"J Nat Med"},{"key":"954_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.carbpol.2010.03.014","volume":"81","author":"JB Lee","year":"2010","unstructured":"Lee JB, Koizumi S, Hayashi K, Hayashi T (2010) Structure of rhamnan sulfate from the green alga Monostroma nitidum and its anti-herpetic effect. Carbohydr Polym 81:572\u2013577","journal-title":"Carbohydr Polym"},{"key":"954_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.11648\/j.ajac.20170502.13","volume":"5","author":"M Tako","year":"2017","unstructured":"Tako M, Yamashiro Y, Teruya T, Uechi S (2017) Structure-function relationship of rhamnan sulfate isolated from commercially cultured edible green seaweed, Monostroma nitidum. Am J Appl Chem 5:38\u201344","journal-title":"Am J Appl Chem"},{"key":"954_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/md20020121","volume":"20","author":"M Terasawa","year":"2022","unstructured":"Terasawa M, Hiramoto K, Uchida R, Suzuki K (2022) Anti-inflammatory activity of orally administered Monostroma nitidum rhamnan sulfate against lipopolysaccharide-induced damage to mouse organs and vascular endothelium. Mar Drugs 20:121","journal-title":"Mar Drugs"},{"key":"954_CR17","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.1038\/s41598-021-92459-7","volume":"11","author":"Y Shimada","year":"2021","unstructured":"Shimada Y, Terasawa M, Okazaki F, Nakayama H, Zang L, Nishiura K et al (2021) Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial. Sci Rep 11:13384","journal-title":"Sci Rep"},{"issue":"22","key":"954_CR18","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3390\/cells12222666","volume":"12","author":"M Terasawa","year":"2023","unstructured":"Terasawa M, Zhang L, Hiramoto K, Shimada Y, Mitsunaka M, Uchida R et al (2023) Oral administration of rhamnan sulfate from Monostroma nitidum suppresses atherosclerosis in ApoE-deficient mice fed a high-fat diet. Cells 12(22):2666","journal-title":"Cells"},{"issue":"7","key":"954_CR19","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"NP du Sert","year":"2020","unstructured":"du Sert NP, Hurst V, Ahluwalia A, Alam S, Avey MT et al (2020) The ARRIVE guideline 2.0: Update guidelines for reporting animal research. PLoS Biol 18(7):e3000410","journal-title":"PLoS Biol"},{"issue":"2","key":"954_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100(2):174\u2013190","journal-title":"Circ Res"},{"key":"954_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13054-017-1841-8","volume":"21","author":"H Okada","year":"2017","unstructured":"Okada H, Takemura G, Suzuki K, Oda K, Takeda C, Hotta Y et al (2017) Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions. Crit Care 21:261","journal-title":"Crit Care"},{"key":"954_CR22","doi-asserted-by":"publisher","first-page":"149286","DOI":"10.1016\/j.bbrc.2023.149286","volume":"691","author":"K Ohmura","year":"2024","unstructured":"Ohmura K, Kinoshita T, Tomita H, Okada H, Shimizu M, Mori K et al (2024) Prevention of vincristine-induced peripheral neuropathy by protecting the endothelial glycocalyx shedding. Biochem Biophys Res Commun 691:149286","journal-title":"Biochem Biophys Res Commun"},{"key":"954_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.trsl.2022.03.014","volume":"247","author":"A Suzuki","year":"2022","unstructured":"Suzuki A, Tomita H, Okada H (2022) Form follows function: the endothelial glycocalyx. Transl Res 247:158\u2013167","journal-title":"Transl Res"},{"key":"954_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.mvr.2011.08.008","volume":"82","author":"P Bansch","year":"2011","unstructured":"Bansch P, Nelson A, Ohlsson T, Bentzer P (2011) Effect of charge on microvascular permeability in early experimental sepsis in the rat. Microvasc Res 82:339\u2013345","journal-title":"Microvasc Res"},{"key":"954_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ph10030070","volume":"10","author":"AEI Proudfoot","year":"2017","unstructured":"Proudfoot AEI, Johnson Z, Bonvin P, Handel TM (2017) Glycosaminoglycan interactions with chemokines add complexity to a complex system. Pharmaceuticals (Basel) 10:70","journal-title":"Pharmaceuticals (Basel)"},{"key":"954_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/01.ATV.0000046238.23903.FC","volume":"23","author":"KG Mann","year":"2003","unstructured":"Mann KG, Butenas S, Brummel K (2003) The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 23:17\u201325","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1172\/JCI200318234","volume":"111","author":"JI Weitz","year":"2003","unstructured":"Weitz JI (2003) Heparan sulfate: antithrombotic or not? J Clin Invest 111:952\u2013954","journal-title":"J Clin Invest"},{"key":"954_CR28","doi-asserted-by":"publisher","first-page":"e86249","DOI":"10.1371\/journal.pone.0086249","volume":"9","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Tarbell JM (2014) The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS ONE 9:e86249","journal-title":"PLoS ONE"},{"key":"954_CR29","doi-asserted-by":"publisher","first-page":"H1023","DOI":"10.1152\/ajpheart.00162.2007","volume":"293","author":"Y Yao","year":"2007","unstructured":"Yao Y, Rabodzey A, Dewey CF Jr (2007) Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress. Am J Physiol Heart Circ Physiol 293:H1023\u2013H1030","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"954_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/biomimetics7030087","volume":"7","author":"RB Diller","year":"2022","unstructured":"Diller RB, Tabor AJ (2022) The role of the extracellular matrix (ECM) in wound healing: a review. Biomimetics (Basel) 7:87","journal-title":"Biomimetics (Basel)"},{"key":"954_CR31","doi-asserted-by":"publisher","first-page":"106192","DOI":"10.1016\/j.fbio.2025.106192","volume":"66","author":"S Tochitani","year":"2025","unstructured":"Tochitani S, Kisohara H, Nakamura K, Hiramoto K, Terasawa M, Suzuki K (2025) An edible seaweed-derived rhamnan sulfate modulates gut microbiota by promoting Mucispirillum schaedleri through bacterial interactions and enhancing anti-inflammatory and pathogen-protection mechanisms in mice. Food Biosci 66:106192","journal-title":"Food Biosci"},{"issue":"5","key":"954_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/md18050254","volume":"18","author":"M Terasawa","year":"2020","unstructured":"Terasawa M, Hayashi K, Lee J-B, Nishiura K, Matsuda K, Hayashi T et al (2020) Anti-influenza a virus activity of Rhamnan Sulfate from green algae Monostroma nitidum in mice with normal and compromised immunity. Mar Drugs 18(5):254","journal-title":"Mar Drugs"},{"key":"954_CR33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/jth.15266","volume":"19","author":"AS Eustes","year":"2021","unstructured":"Eustes AS, Campbell RA, Middleton EA, Tolley ND, Manne BK, Montenont E et al (2021) Heparanase expression and activity are increased in platelets during clinical sepsis. J Thromb Haemost 19:1319\u20131330","journal-title":"J Thromb Haemost"},{"key":"954_CR34","doi-asserted-by":"publisher","first-page":"100097","DOI":"10.1016\/j.mbplus.2021.100097","volume":"13","author":"V Masola","year":"2021","unstructured":"Masola V, Greco N, Gambaro G, Franchi M, Onisto M (2021) Heparanase as active player in endothelial glycocalyx remodeling. Matrix Biol Plus 13:100097","journal-title":"Matrix Biol Plus"},{"key":"954_CR35","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.3389\/fimmu.2018.02787","volume":"9","author":"P Johnson","year":"2020","unstructured":"Johnson P, Arif AA, Lee-Sayer SSM, Dong Y (2020) Hyaluronan and its interactions with immune cells in the healthy and inflamed lung. Front Immunol 9:2787","journal-title":"Front Immunol"},{"key":"954_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","volume":"23","author":"R Uchimido","year":"2019","unstructured":"Uchimido R, Schmidt EP, Shapiro NI (2019) The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care 23:16","journal-title":"Crit Care"},{"key":"954_CR37","doi-asserted-by":"publisher","first-page":"e0186116","DOI":"10.1371\/journal.pone.0186116","volume":"12","author":"SA Mensah","year":"2017","unstructured":"Mensah SA, Cheng MJ, Homayoni H, Plouffe BD, Coury AJ, Ebong EE (2017) Regeneration of glycocalyx by heparan sulfate and sphingosine 1-phosphate restores inter-endothelial communication. PLoS ONE 12:e0186116","journal-title":"PLoS ONE"},{"key":"954_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yexcr.2015.08.013","volume":"339","author":"Y Zeng","year":"2015","unstructured":"Zeng Y, Liu XH, Tarbell J, Fu B (2015) Sphingosine 1-phosphate induced synthesis of glycocalyx on endothelial cells. Exp Cell Res 339:90\u201395","journal-title":"Exp Cell Res"},{"key":"954_CR39","doi-asserted-by":"publisher","first-page":"H363","DOI":"10.1152\/ajpheart.00687.2013","volume":"306","author":"Y Zeng","year":"2014","unstructured":"Zeng Y, Adamson RH, Curry FRE, Tarbell JM (2014) Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am J Physiol Heart Circ Physiol 306:H363\u2013H372","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"954_CR40","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm.2843","volume":"18","author":"EP Schmidt","year":"2012","unstructured":"Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L et al (2012) The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 18:1217\u20131223","journal-title":"Nat Med"},{"key":"954_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","volume":"29","author":"I Vlodavsky","year":"2016","unstructured":"Vlodavsky I, Singh P, Boyango I, Gutter-Kapon L, Elkin M, Sanderson RD et al (2016) Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat 29:54\u201375","journal-title":"Drug Resist Updat"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-026-00954-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:03:17Z","timestamp":1784534597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-026-00954-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1186\/s40635-026-00954-w","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol received approval from the Institutional Animal Research Committee at Osaka Medical and Pharmaceutical University in Osaka, Japan (approval number: MA24-013 and MA26-031).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RH reports receiving funding from Konan Chemical Manufacturing Co., Ltd. MT is an employee of Konan Chemical Manufacturing Co., Ltd., which provided funding and supplied the RS used in this study. The company had no role in the study design, data acquisition, data analysis, or manuscript preparation. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"98"}}